Emerging Trends in Oral Delivery of Peptide and Protein Drugs

Abstract

Most peptide and protein drugs are currently used as parenteral formulations because of their poor oral bioavailability. Development of an effective oral delivery system for these macromolecular drugs requires a thorough understanding of their physicochemical properties, such as molecular weight, hydrophobicity, ionization constants, and pH stability, as well as biological barriers that restrict protein and peptide absorption from the gastrointestinal (GI) tract, including pH variability, enzymatic degradation, and membrane efflux. Various strategies currently under investigation include amino acid backbone modifications, formulation approaches, chemical conjugation of hydrophobic or targeting ligand, and use of enzyme inhibitors, mucoadhesive polymers, and absorption enhancers. However, there is only limited success because of the hostile environment of the GI tract--e.g., strong pH extremes and abundant presence of potent luminal enzymes. This review focuses on the challenges posed by the GI system and how different pharmaceutical approaches can be used to make oral delivery of protein and peptide drugs more feasible. The roles of P-glycoprotein and CYP3A4 in controlling the extent of intestinal absorption and metabolism will also be discussed.

Permeability of Exendin-4-Loaded Chitosan Nanoparticles across MDCK Cell Monolayers and Rat Small Intestine

“…9,10) Our previous study demonstrated that the apparent permeability coefficient (P app ) of exendin-4 across the Madin Darby canine kidney (MDCK) cell monolayer was approximately 1×10…”

Preparation and Characterization of Salmon Calcitonin–biotin Conjugates

“…In addition, during the transit through the intestinal tract, they are chemically and enzymatically inactivated by the high acidity of the stomach and the presence of nutrients and secreted enzymes. Nevertheless, oral delivery is a very attractive option for administration of many proteins (30,31).…”

Plant-expressed Hepatitis B core antigen virus-like particles: Characterization and investigation of their stability in simulated and pig gastro-intestinal fluids

“…The first physicochemical barrier encountered in the gastro-intestinal (GI) tract is constituted by the stomach fluid: the pH in the stomach generally ranges from pH 1.0 to 2.5 in the normal fasted state condition (Evans et al, 1988). Furthermore, the stomach fluid is rich in the enzyme pepsin that constitutes a further biochemical barrier to proteins (Mahato et al, 2003). The intestine has a more neutral pH than the stomach, generally ranging from pH 6.3 to 7.5 (Evans et al, 1988).…”

“…The intestine has a more neutral pH than the stomach, generally ranging from pH 6.3 to 7.5 (Evans et al, 1988). However, the intestinal fluid also represents a biochemical threat to the stability of therapeutic proteins, mainly due to the presence of pancreatic enzymes including trypsin and chymotrypsin (Mahato et al, 2003). In recent years, systems based on the use of nanoparticulate carriers, encapsulating and hence protecting labile proteins through their passage in the GI tract, have been investigated as possible options for the successful oral delivery of proteins (Kammona and Kiparissides, 2012).…”